HomeQuestion

How often do you monitor LFTs when starting Avacopan?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

How do you treat IgA vasculitis with gastrointestinal involvement?

Do you continue PJP prophylaxis indefinitely in patients on rituximab maintenance therapy?

Would you consider anti-IL-5 therapy (mepolizumab or benralizumab) to either prevent or treat the more severe manifestations of eosinophilic granulomatosis with polyangiitis, such as "infiltrative" (e.g., cardiomyopathy, pulmonary infiltrates, or gastroenteritis) or "vasculitic" (e.g., neuropathy, palpable purpura, or glomerulonephritis)?

How would you approach induction therapy for EGPA with neurological involvement in a middle-aged patient with foot drop and axonal peripheral neuropathy on EMG, but otherwise no evidence of GI/renal/cardiovascular involvement?

How would you approach treatment of suspected EGPA presenting with progressive neuropathy and sural nerve biopsy with eosinophilia, but no evidence of vasculitis?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.

How often do you monitor LFTs when starting Avacopan? | Mednet